Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the acf domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/vhosts/viewstream-media.com/cri.viewstream-media.com/wp-includes/functions.php on line 6131

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/vhosts/viewstream-media.com/cri.viewstream-media.com/wp-includes/functions.php on line 6131

Notice: Undefined offset: 0 in /var/www/vhosts/viewstream-media.com/cri.viewstream-media.com/wp-content/themes/cri/single.php on line 10

Notice: Trying to get property 'name' of non-object in /var/www/vhosts/viewstream-media.com/cri.viewstream-media.com/wp-content/themes/cri/single.php on line 10
XVth NIBIT Meeting: Cancer Bio-Immunotherapy in Siena - Cancer Research Institute
stdClass Object ( [getLoginUrlResponse] => stdClass Object ( [JSESSIONID] => 0899FBA2A3CE7688BB7EB248E1244886.app30133b [routing_id] => 00000000.app30133b [url] => https://give.cancerresearch.org/site/CRConsAPI;jsessionid=00000000.app30133b?NONCE_TOKEN=200B193E31AF30C7EE81AE9170ABD174 [token] => 2ltxx-qYbnNasKE937METO40ZcjaCKy_i2fZrltEFI5RGqms753wohTMbrDwfGce2XNat-sP5LODPMdWcWYNL5Qrt7tlU-yvqx0KGdo ) ) test

Cancer Research Institute Event Calendar

Subscribe

Share

XVth NIBIT Meeting: Cancer Bio-Immunotherapy in Siena

Bio-immunotherapy of cancer provides compelling proof of clinical success in the comprehensive treatment of human malignancies. The Italian Network for Cancer Biotherapy (NIBIT), a non-profit association established in 2004, gathers national groups focused on clinical and pre-clinical research in cancer immunotherapy and biotherapy each year to discuss the latest advances in the field. The NIBIT has convened the international meeting "Cancer Bio-Immunotherapy in Siena" together with its XVth annual Congress. 

Aiman Shalabi, Pharm.D., MBA, BCOP, chief medical officer of the Cancer Research Institute, presents on Saturday, October 7, 2017 in the "Prospective NIBIT and NIBIT Foundation collaborations" session. 

“A Vision of I-O: The Siena Consensus," a think tank meeting convened by the NIBIT Foundation, will immediately follow the meeting on October 7, 2017 (3:00pm-6:00pm) in Siena, Italy. Aiman Shalabi in attendance. Topics for discussion include: 

  1. Agonistic antibodies in the era of antagonistic antibodies: monotherapy, combination and/or sequence
    Introduced by: Bernie Fox (WIC/KOL) and Axel Hoos (GSK)
  2. A common denominator among I-O "Omics (mutatome, transcriptome, epigenome, metabolome, proteome, microbiome, etc) to drive the future of immunotherapy: a reachable goal or simply an utopia?
    Introduced by: George Coukos (KOL) and Dominik Ruettinger (Roche)
  3. Pharmacodynamic biomarkers in the peripheral blood: a worth exploring field
    Introduced by: Jedd Wolchok (KOL) and Jean Viallet (BMS)
  4. Bringing to reality novel ideas from young scientists: can "The Siena I-O Consensus Panel" help?
    Introduced by: Ramy Ibrahim (Parker) and Wolf Fridman (KOL)

Read more:

This site is registered on wpml.org as a development site.